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Summary 
Protein secretion is conventionally 
viewed as taking place by either of two 
cellular routes, a regulated pathway, 
involving external stimuli and secretory 
granules, unda presumptive ‘constitutive’ 
pathway, which doesnot involve hormonal 
or neuronal stimuli or the production of 
secretory granules. The evidence reviewed 
here strongly suggests that there are 
post-synthesis rate-limiting steps for 
many proteins released by the ’ constitut- 
ive’ pathway and, hence, that regulation 
in some sense is involved here too. The 
nature of these rate-limiting determinants 
and events is discussed. 
Introduction 
The question posed in the title of this 
article implies a paradox. Indeed, it has 
been thought by some that proteins not 
packaged into secretory vesicles for later 
release or not directed to a specific 
intracellular organelle by some post- 
translationally added signal (e.g. the 
mannose-6-phosphate modification of 
lysosomal enzymes) move through the 
cell via a continuous process that is 
essentially unregulated in the sense that 
it is passive and merely reflects ‘bulk 
flow’ of cellular material between intra- 
cellular compartments. Thus, in this 
view, the rate of secretion would be 
determined primarily by the rate of 
secretory protein synthesis. If this were 
the case, one would then expect that 
continuously secreted proteins, not 
stored in typical secretory vesicles for 
exocytosis in response to an external 
signal, would be secreted at the same or 
very similar rates as long as their 
biosynthetic rates were similar. We take 
the opposite point of view and will focus 
on the mechanisms of secretion of 
continuously secreted proteins and on 
potential mechanisms involved in regul- 
ation of their intracellular translocation 
and secretion. 
Protein Secretory Pathways 
Two general pathways are known to 
exist for the secretion of proteins from 
within the cell. The classic work of 
Palade and his colleagues’ on the 
pancreatic acinar cell, in which zymogen 
is stored in secretory vesicles and 
dependent on stimuli for secretion, 
typifies one type of secretory pathway. 
Secretion from pancreatic acinar cells is 
regulated by neuronal or hormonal 
signals. This secretory process is defined 
by several discrete events: (1) synthesis 
in the rough endoplasmic reticulum 
(RER), (2) translocation from RER to 
Golgi, (3) sorting and segregation in the 
Golgi, (4) concentration and storage in 
secretory vesicles, ( 5 )  translocation to 
the cell surface and (6) secretion. The 
second step, translocation of protein 
from the rough endoplasmic reticulum 
to the Golgi apparatus, is energy- 
dependent. The third event is where 
secretory products are sorted into 
different pathways for export. The next 
step, in which condensing vacuoles, 
presumably generated from the Golgi 
membranes, become mature secretion 
vacuoles, is not dependent on energy, 
but is dependent on intracellular ionic 
gradients. The final step, secretion, 
requires both energy and Ca2+, is 
stimulated by depolarization events at 
the plasma membranes and can proceed 
in the absence of protein synthesis. This 
so-called ‘regulated pathway’ is found 
in specialized secretory cells, such as 
exocrine and endocrine cells, neurons, 
neutrophils, and mast cells. 
A second secretory pathway is ob- 
served in some cells, including fibro- 
blasts, chondrocytes, liver parenchymal 
cells, macrophages, and B lymphocytes. 
In these cells, the concentration step is 
omitted, secretory granules are not 
found, and intracellular storage of 
proteins is diminished or omitted. Ths 
type of secretion is said to be continuous 
or ‘constitutive’. In contrast to the 
regulated secretory pathway, the rate of 
secretion by the constitutive pathway is 
not dependent on hormonal or neuronal 
stimulation, cytoplasmic cyclic nucleo- 
tide levels or, in most cases, the integrity 
of colchicine- and cytochalasin-sensitive 
structures such as microtubules and 
microfilaments.2g 
Some cells are capable of processing 
secretory proteins by both types of 
pathways. An example is the AtT-20 cell 
line, a transformed mouse pituitary cell 
line in which the precursor of ACTH, 
pro-opiomelanocortin. (POMC), is 
cleaved into mature ACTH, which is 
then packaged into secretory granules 
and secreted upon stimulation of 
the cells with a secretagogue such as 
8-bromoadenosine-3’,5’-cyclic mono- 
phosphate (8 Br-CAMP). Some POMC 
is also secreted, but by a constitutive 
pathway that is insensitive to secretago- 
gues that increase the release of 
ACTH.4.5 A summary of differences 
between the regulated and constitutive 
secretory pathway is shown in Table I .  
The mechanisms involved in the 
regulated pathway have been recently 
reviewed.6 The observations that some 
cell types have both pathways, that the 
half-time for transport from the Golgi 
apparatus to the cell surface is long for 
proteins in the regulated pathways 
(q z 10 h)compared to those transloca- 
ted to the cell surface by the constitutive 
pathway (ti z 10 min), and that some 
proteins are retained in organelles along 
the pathway (e.g. cytochrome P-450 in 
the RER), while others proceed through 
the cell into specific organelles (e.g. 
lysosomes, secretory vesicles) indicate 
that a ‘ sorting’ mechanism exists in cells 
to direct translocated products into 
these different pathways. It should be 
noted that certain integral membrane 
proteins are also sorted and translocated 
to the cell surface via a constitutive 
mechanism that is similar to that of 
continuously secreted proteins. 
For the regulated pathway, there is 
evidence to suggest that sorting occurs 
in the Golgi apparatus and that the 
molecular basis of this sorting depends 
on a ‘sorting domain’ of the secretory 
protein and on a ‘carrier’ that recognizes 
the sorting domain and directs the 
secretory protein into its correct secret- 
ory pathway.‘j Transfection of recipient 
cells that have both the constitutive and 
regulated secretory pathways with genes 
encoding proteins destined to have 
regulated secretion in their parent 
(donor) cell type (e.g. pro-insulin, 
growth hormone, parathyroid hormone, 
Secretory products 
concentrated and stored 




Limited to specialized 
secretory cells 
Secretion stimulated by 
external secretagogues, e.g. 
hormones and membrane- 
depolarizing events 
Secretion of stored 
protein not dependent 
on new protein synthesis 
Rate of secretory protein 
translocation from Golgi 
to cell surface is delayed 
( t ,  10 h) 
Rite limiting step is 
exocytosis 
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TABLE I .  Summary of differences between the regulated and constitutive secretory 
pathways 
with [35S]methionine, but gp 70 does not 
reach the cell membrane in detectable 
amounts until 90min into the chase 
Regulated Constitutive period. This difference is due to a slow 
step in gp 70 processing that coincides 
with proteolytic cleavage of the precur- 
sor of gp 70. Gp 70 resides for a longer 
Concentration and storage 
steps are missing 
Secretory vesicles not 
observed 
Occurs in all cell types 
Secretion is continuous and 
not secretagogue-dependent 
Secretion parallels amount 
of protein synthesized 
Rate of secretory protein 
translocation from Golgi 
to cell surface is rapid 
(rt z 1 0  mjn) 
Rate-limiting step is RER- 
Golgi translocation 
period of time ih the RER than doesgp 
93. Since both of these proteins are 
translocated to the cell surface via a 
‘constitutive’ pathway, these data argue 
against a strict passive flow process for 
this mechanism. These authors propose 
that plasma membrane proteins contain 
a signal in their amino acid sequence 
that mediates their export from the 
RER. 
Lodish et d . 1 °  studied the rates of 
secretion of five constitutively secreted 
proteins synthesized in cultured human 
hepatoma (Hep G2) cells. Half-times for 
secretion were shown to vary by as much 
as threefold. For exampie, -50% of 
and trypsinogen) has shown that these 
proteins are packaged into secretory 
vesiclesandco-released with the recipient 
cells’ endogenous, regulated secretory 
proteins upon stimulation with 
secretagogue.6 An implication of this 
finding is that proteins secreted via the 
regulated pathway should have a shared 
sorting domain amino acid sequence 
that would be involved in their recogni- 
tion of the carrier. No such common 
amino acid sequence has been found so 
far, but carrier recognition sequences 
may be analogous to the signal peptides 
of proteins synthesized in the RER for 
export; these signal peptides also lack a 
common primary amino acid sequence 
homology, yet recognize a common 
signal peptide recognition particle. 
Based on a number of lines of 
evidence, it has been postulated that the 
regulated pathway has specific carrier- 
mediated intracellular translocation, 
whereas the constitutive pathway does 
not.6y8 The evidence is as follows. (1) 
Treatment of AtT-20 cells with the weak 
base chloroquine diverts ACTH from 
the regulated to theconstitutive pathway, 
suggesting that the latter pathway does 
not require specific signals. (2) Trans- 
fection of AtT-20 cells with DNA se- 
quences encoding vesicular stomatitis 
Virus (VSV) membrane protein (G 
protein) lacking the membrane spanning 
domain converts VSV-G protein into a 
secretory protein that is secreted selec- 
tively via the constitutive pathway, 
whereas the same cells transfected with 
the human growth hormone (hGH) 
gene co-secrete hGH with ACTH via the 
regulated pathway. (3) POMC, the viral 
membrane glycoprotein gp 70, and the 
extracellular matrix protein laminin are 
all translocated to the cell surface by 
AtT-20 cells via a constitutive mecha- 
nism with similar kinetics. These 
authors6,B thus postulate that the trans- 
port of secretory proteins in 
constitutively secreting cells is a passive, 
bulk flow mechanism not involving 
targeting information or carrier-medi- 
ated sorting. In this review, we would 
like to propose a different hypothesis, 
namely that the so-called constitutive 
pathway is in fact a regulated pathway, 
but that the regulation occurs at earlier 
steps in the intracellular translocation 
sequence than is the case for the 
‘regulated’ pathway. It should be noted 
here that it’ is likely that similar 
regulatory mechanisms occur in the 
pre-Golgi portions of both pathways 
and that the two pathways diverge in the 
Golgi. 
Translocation from RER to 
Golgi: Evidence for Regulated 
Steps in Continuously Secreting 
Cells 
Fitting andKabatg analysed the synthesis 
and kinetics of intracellular transport of 
two Friend murine leukemia virus 
(MuLV) membrane glycoproteins in 
virally infected mouse cells. The two 
glycoproteins, gp 70 and gp 93, although 
synthesized at similar rates, reach the 
cell surface at different rates. Maximum 
incorporation of gp 93 into the plasma 
membrane occurs at 60 min after initia- 
tion of chase in a pulse-chase experiment 
albumin and a,-antitrypsin is secreted in 
45 min after biosynthetic labelling; half 
of the labelled C3 complement compo- 
nent and a,-antichymotrypsin are re- 
leased in 85-90 min, and half the label- 
led transferrin is secreted in 140min. 
The differences between the rates of sec- 
retion of these proteins appear to be due 
to the differences in rate of translocation 
from RER to Golgi, arguing against 
bulk flow between these two organelles 
and suggesting some selective, perhaps 
carrier-mediated event. 
Ye0 et uL1, used cell fractionation 
techniques, lectin affinity, and sensitivity 
to the glycosidase endo H, which cleaves 
primarily the high mannose-containing 
oligosaccharides found in glycoproteins 
localized in the RER, to examine the 
rates of intracellular translocation and 
secretion of transferrin, ceruloplasmin, 
and a,-antitrypsin by cultured human 
hepatoma cells. These three substrates 
are secreted at very different rates, have 
different half-times for translocation 
from RER to Golgi and, in addition, 
have different apparent rates of trans- 
location through the Golgi. 
Peters et c ~ 1 . l ~ .  l3 have studied the rates 
of biosynthesis, processing, and secre- 
tion of chorionic gonadotropin (hCG) 
and laminin, two glycoproteins secreted 
continuously by cultured human chorio- 
carcinoma (JAR) cells. Although the 
biosynthesis of these glycoproteins and 
the initial steps in their oligosaccharide 
processing occur at similar rates, their 
rates of release from the cell differ 
markedly. The half-time for release of 
hCG from JAR cells is 35 min and that 
of laminin 100 min. Based on deter- 
mination of the oligosaccharide com- 
position, the rate-limiting step in 
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release of hCG and laminin is transloca- 
tion from RER to Golgi. 
The intracellular transport of two 
highly homologous class I histocompati- 
bility antigens, H-2Kk and H-2Dk, has 
been determined in a murine B cell 
lymphoma cell line by Williams et ul.14 
Newly synthesized H-2Kk reaches the 
cell surface within 1 h, whereas H-2Dk 
is transported much more slowly 
(tl = 4-5 h) to the cell surface. The rates 
of translocation to the cell surface of 
these two glycoproteins parallel the 
rates at which their asparagine-linked 
oligosaccharides are processed to endo 
H-resistance, suggesting that the rate- 
limiting step is transport from RER to 
Golgi. 
Taken together, these data are incom- 
patible with a passive, bulk flow model 
for continuously or constitutively sec- 
reted molecules and suggest some type 
of substrate-specific process that regula- 
tes the rate of their secretion. The 
concept that the secretion of these 
substrates is regulated only by their rate 
of biosynthesis is also excluded by the 
results cited above. 
Characteristics of 
Substrate-Specific lntracellular 
Trans1 ocat i o n Events 
The rate-limiting event for a number of 
continuously secreted proteins appears 
to be translocation from RER to Golgi. 
Lodish et d . 1 °  have postulated that a 
receptor protein in the RER membrane 
regulates selective accumulation of sec- 
retory proteins into transport vesicles en 
route to the Golgi. Faster-migrating 
proteins might have a higher affinity for 
this receptor than slowly migrating 
proteins. An alternative explanation is 
that each secretory protein has its own 
receptor, each of which has a character- 
istic rate of incorporation into a trans- 
port vesicle. The amount of receptor 
in the RER membrane could be deter- 
mined by the rate of synthesis and 
turnover of the receptor, its rate of 
incorporation into the RER membrane 
and its ability to cluster in the ‘budding’ 
area of RER membrane involved in 
vesicle formation. There is a precedent 
for this latter suggestion in receptor- 
mediated endocytosis, where attachment 
of a ligand to its receptor mediates 
clustering or patching of the receptors in 
the plasma membrane prior to formation 
of the endocytic vesicle.1s 
Recognition of such transport recep- 
tors could be via recognition signals 
determined by the polypeptide (either its 
primary amino acid sequence or confor- 
mation) or, in the case of glycoproteins, 






















Fig. 1. Schematic represenration of steps in the synihesis, processing and secretion ofglycoproteins. The 
points at which FCCP, methylamine, and monensin block the intracellular translocation of glycoproteins 
are depicted. Processing enzymes include GI, glucosidase I ;  GII, glucosidase I I ;  SP,  signal peptidase; 
MI, mannosidase I (both RER and Golgi forms); MII, mannosidase I I ;  GnT I ,  N-aceiylglucosaminyl 
transferase I ;  Gn T III, N-acetylglucosaminyl transferase III. Under certain conditions, such as inhibition 
of mannosidase I I  by swainsonine, ‘hybrid’ oligosaccharide chains may be formed and be present on secreted 
glycoproteins. (From Peters et a1.,23 with permission.) 
either by the polypeptide or by the 
oligosaccharide structure or both. There 
is evidence that both protein and 
carbohydrate structure may be involved 
in translocation events for secretory 
proteins. For example, mutant genes 
encoding viral membrane glycoproteins 
of Rous sarcoma virus (RSV) and of 
VSV that are missing various portions 
of the transmembrane and cytoplasmic 
domains (i.e. the part of the polypeptide 
on the cytoplasmic as opposed to the 
cisternal face of the RER) have been 
transfected into cells and translocation 
and secretion of their respective gene 
products studied.l6? l7 The RSV mutant 
glycoproteins lacking the transmem- 
brane and the cytoplasmic domains and 
VSV glycoproteins lacking the cytoplas- 
mic domain were retained in the RER 
and not translocated to the Golgi. These 
results suggest that the mutant proteins 
lack a translocating signal for transit to 
the Golgi. 
Studies with glycosidase inhibitors 
suggest that for certain glycoproteins 
translocation signals may involve the 
structure of their oligosaccharides. The 
use of glycoproteins to study transloca- 
tion events has the advantage that the 
glycosidases and glycosyltransferase in- 
volved in their synthesis and processing 
are distinctly compartmentalized in the 
RER and Golgi apparatus (Fig. ]).la 
Thus the oligosaccharide composition 
of cellular glycoproteins serves as a 
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TABLE ZI. Effects of various inhibitors of protein secretion 
Agent Site of inhibition 











Synthesis of lipidxarbohydrate 
carrier complex for high mannose 
asparagine-linked oligosaccharide 
Glucosidase I and I1 
Glucosidase I and I1 
Glucosidase I and I1 
Mannosidase I 
Mannosidase I1 
Monovalent cation equilibrium 
Intracellular pH gradients 
Oxidative phosphorylation; 
intracellular pH gradients 
Blocks secretion of some 
but not all glycoproteins 
and leads to their 
retention in the RER 
Retention of certain 
glycoproteins in the RER 
Retention of certain 
glycoproteins in the RER 
Retention of certain 
glycoproteins in the RER 
Slight or no inhibition 
of glycoprotein secretion 
Slight or no inhibition 
of glycoprotein secretion 
Produces intra-Golgi block 
of secretion 
Blocks RERGolgi trans- 
location 
Blocks RER-Colgi trans- 
location 
marker of their intracellular location. 
Various drugs that have been shown to 
block oligosaccharide synthesis or pro- 
cessing have been utilized to examine 
glycoprotein translocation and secre- 
tion. The site of action of such drugs is 
shown in Table 2. 
Tunicamycin is a drug that blocks 
addition ofasparagine-linked (N-linked) 
oligosaccharide chains to glycoproteins 
by preventing formation of the dolichol- 
linked Glc,Man,GlcNAc, intermediate. 
Using this drug it has been shown that 
glycosylation is required for secretion of 
some glycoproteins such as IgA, IgE, 
and IgM from mouse plasmacytoma 
cells and a-macroglobulin, a,-anti- 
trypsin, and ceruloplasmin from human 
Hep G2 hepatoma cells (reviewed in ref. 
19). Cell fractionation studies have 
shown that the nonglycosylated proteins 
remain in the RER.lg Additional evi- 
dence indicating a role for oligosaccha- 
rides in translocation and secretion of 
glycoproteins comes from studies with 
agents that block enzymes involved in 
trimming the carbohydrate chains, i.e. 
glucosidase I and II and a-mannosidase 
I and II.19,20 Treatment of Hep G2 cells 
with the glucosidase inhibitor l-de- 
oxynojirimycin blocks trimming of glu- 
cose residues from high-mannose 
oligosaccharides and inhibits transloca- 
tion as well as secretion of or,-macro- 
globulin, ceruloplasmin, transferrin, 
and a,-antitrypsin by these cells but not 
translocation and secretion of albumin 
or VSV-G protein. The non-secreted 
glycoproteins accumulate in the RER, 
suggesting that trimming of the terminal 
glucose residues of N-linked oligosacch- 
arides is a prerequisite for export of 
secretory glycoproteins from the RER. 
Similarly, the translocation of lysosomal 
enzymes cathepsin D and hexosamini- 
dase from RER to Golgi is inhibited by 
1 -deoxynojirimycin in cultured human 
diploid fibroblasts, 
The best case for the involvement of 
oligosaccharides in translocation events 
comes from lysosomal enzymes that 
require formation of 6-phosphomanno- 
syl groups on their N-linked oligosacch- 
aride chains for transport to the 
lysosomes. Treatment of fibroblasts, for 
example, with tunicamycin or I-deoxy- 
nojirimycin decreases the targeting of 
lysosomal hydrolases to lysosomes by 
preventing formation of the 6-phospho- 
mannosyl group and causes their con- 
stitutive release from cells.19 
Taken together, these results indicate 
that N-linked oligosaccharides play an 
important regulatory role in the intra- 
cellular transport and secretion of 
glycoproteins and imply that a receptor 
or carrier invoked in the RER-Golgi 
translocation recognizes either the car- 
bohydrate moiety itself or a conforma- 
tional structure imposed on the 
glycoprotein by the presence of the 
oligosaccharide. 
Role of Ionic Gradients in 
Translocation and Secretion 
Agents that disrupt intracellular mono- 
valent cation gradients in cells block 
intracellular translocation and secretion 
of a number of secretory proteins. For 
example, in a study of JAR choriocarci- 
noma cells, Peters et a1.22. 23 have shown 
that FCCP, methylamine, and monensin, 
three agents that collapse hydrogen ion 
gradients across cellular membranes by 
different mechanisms, inhibit oligosac- 
charide processing and secretion of 
hCG. FCCP and methylamine produce 
the accumulation of Man,_,GlcNAc, by 
JAR cells. The accumulation of these 
precursors indicates blockade of RER 
to Golgi translocation (Fig. 1). On the 
other hand, monensin produces an 
intraGolgi blockade of translocation 
leading to the accumulation of 
Man,GlcNAc,-containing hCG sub- 
units. CCCP, an analog of FCCP, also 
blocks RER-Golgi translocation of 
secretory proteins such as pancreatic 
zymogen~,~~ collagen,25 immunoglobu- 
lin,, and thyroglobulin.26 Monensin has 
been shown to produce accumulation 
in the Golgi and to block secretion 
of a number of secretory proteins, in- 
cluding immunoglobulin,2 tran~ferrin,~~ 
fibronectin,28 procollagen,2B and viral 
membrane glyc~proteins.~’ Although a 
number of these agents also lower 
cellular ATP levels, it has been shown 
that effects on secretion and oligosac- 
charide processing can be achieved at 
concentrations that do not significantly 
lower ATP.23. Thus, these results impli- 
cate an important role for hydrogen ion 
gradients in regulating intracellular 
translocation and secretion of proteins 
from cells. 
Translocation from the Golgi to 
Plasma Membrane 
It is this step that distinguishes most 
clearly the ‘regulated’ from the ‘consti- 
tutive’ secretory pathways. In the 
regulated pathway, the secretory pro- 
ducts are stored in morphologically 
distinct secretory vesicles and are avail- 
able for rapid release in response to an 
external signal. In the constitutive 
pathway, the translocation between 
Golgi and plasma membrane occurs 
continuously and relatively rapidly 
(ti z 10 min). Yet there must be some 
signals involved in the packaging of 
constitutively secreted products into 
vesicles and in the targeting of those 
vesicles to the appropriate place on the 
cell membrane where secretion can 
occur. Presumably this latter step in- 
volves a vesicle-plasma membrane 
fusion similar to that of the regulated 
pathway; however, as noted above, the 
constitutive pathway has several chara- 
cteristics that distinguish it from the 
regulated type of exocytosis. 
Although the most likely mechanism 
of transport of constitutively secreted 
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products from the Golgi to plasma 
membrane is via vesicular traffic, such 
vesicles have not been definitely identi- 
fied morphologically in cells or isolated 
by cell fractionation techniques. A new 
class of small vesicles, 150-200 nm in 
diameter, has been observed in VSV- 
infected Chinese hamster ovary (CHO) 
cells at the time of initial appearance of 
the VSV-G protein at the cell surface, 
suggesting that these vesicles may be 
involved in post-Golgi transport of 
VSV-G protein.28 Similar vesicles have 
been implicated in the transport of 
Semliki Forest Virus membrane glyco- 
proteins from Golgi to cell surface.30 
Whether these putative post-Golgi 
transport vesicles are in fact the or- 
ganelles that carry out the exocytotic 
event in the constitutive secretory path- 
way awaits further study. 
Conclusion 
In this review we have taken the point 
of view that several sites of regulation 
are present in the intracellular transloc- 
ation and secretion events of the 
so-called constitutive secretory pathway. 
The rate-limiting event in this path- 
way appears to reside primarily at the 
RER-Golgi translocation step, and 
there is considerable circumstantial 
evidence to indicate that this is a carrier- 
or ‘ receptor ‘-mediated event requiring 
some specific signal or signals in either 
the protein or the carbohydrate (or 
both) structure of the secretory pro- 
ducts. Additional points of regulation 
may occur during the ‘shuttle’ of 
secretory proteins between the cis, 
medial, and trans compartments of the 
Golgi. The Golgi-plasma membrane 
step in the constitutive pathway has not 
been well characterized. It most likely 
occurs by vesicle-mediated transport, 
but these vesicles have not been clearly 
identified. At any rate, the steps in- 
volved in secretion in continuously 
secreting cells clearly are regulated 
events, and secretion via the ‘constitu- 
tive’ pathway depends on more than the 
rate of protein synthesis. Thus, in the 
broad sense, to call this an unregulated 
pathway is a misnomer. 
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The presence of small polydisperse 
extrachromosomal circular (spc) DNAs 
composed entirely of chromosomal se- 
quences seems to reflect the plasticity of 
eukaryotic genomes. The size distribution 
and number of spc DNAs is found to vary 
with development, growth state and 
mitotic capacity. In particular, spc DNAs 
are observed to be several fold smaller in 
established immortal cell lines than in 
diploid cells with a limited life span. 
Analysis of cloned spc DNA fragments 
revealed that: ( 1 )  most of the spc DNAs 
thus far investigated contain repetitive 
sequences; (2) some of the repetitive 
sequences are enriched in spc DNA clones 
relative to their representation in the 
chromosome; (3) various repetitive se- 
quences of different reiteration frequency 
were found in spc DNA from immortal 
cell lines while a particular sequence of 
retrovoson was predominant in primary 
lym jhoid tissue cells and stem cells; (4)  
most of these spc DNAs appear to 
represent the extra copies generated by 
replicon-misfiring in immortal cell lines or 
by retrotranscription in stem cells, and 
intermediates or by-products produced 
by abortive rearrangement in diploid 
cells with a finite replicative capacity. 
General Features of spc DNA 
Many eukaryotic cells have been shown 
to contain spc DNAs with a hetero- 
geneous size distribution of from 0.1 to 
more than 2pm (6 kb).' Recently, a 
larger ill-defined population of spc 
DNA ranging in size to more than 
150 kb has been isolated from mouse 
thymocytes.2 The common features of 
spc DNA populations are (1) chromo- 
somal origin and (2) heterogeneity in 
size, total number per cell and nucleotide 
seq~ence.~ In mammalian cells, spc 
DNA was found in both fractions of 
karyoplasts and cyt~plasts.~ By these 
criteria, spc DNA can be distinguished 
from organelle DNAs, plasmids and 
viral DNAs. 
Size Distribution and Copy 
Number of spc DNA 
Extrachromosomal circular DNAs may 
be present in the form of covalently 
closed circular (ccc) DNAs. However, 
the conventional method for isolating 
covalently closed circular (ccc) DNAs is 
a time-consuming and a large-scale pro- 
cess. Recent methodological develop- 
ments involving mica-press-adsorption 
allowed rapid microscale visualization 
of spc DNAs and semi-quantitative 
measurements of the size distribution 
and the number per cell.'$4 
Most, if not all, spc DNAs observed 
by the mica-press-adsorption method 
were attached to a bit of protein or to 
membrane fragments. The spc DNA 
thus examined may be linear with their 
two endslinked by proteins or membrane 
material and stabilized by forming a 
complex. Comparative studies on small 
circular DNAs isolated by different 
methods, the conventional dye-buoyant- 
density method for authentic ccc DNA 
and the mica-press-adsorption method 
for the spc DNA/protein complex, were 
performed. The size distribution and the 
copy number of small circular DNAs 
estimated by these two different methods 
were very similar. Most spc DNA/pro- 
teincomplexes seem to represent authen- 
tic small  circle^.^ 
Every eukaryotic cell studied so far 
has contained spc DNAs. Their size 
distribution and copy number are found 
to vary, depending on the cell source 
(Table 1)1,4-7 The number average of 
contour length is more than 2pm for 
primary lymphoid tissue cells, 1-2 pm 
for secondary lymphoid tissue cells and 
primary cell lines, 0.3-1-0pm for im- 
mortal cell lines, and less than 0.3 pm 
for embryonic stem cells. Every cell 
sourcecan be grouped further arbitrarily 
into two large classes by the threshold 
value of 1 ,urn in average contour length. 
Spc DNAs were several fold larger in 
primary cell lines and cells in situ than 
in transformed cell lines and embryonic 
cells. Copy numbers of spc DNA appear 
to be less in primary cell lines and cells 
in situ than in transformed cell lines and 
embryonal carcinoma (EC) cells. Speci- 
TABLE I .  Properties of spc DNA examined by mica-press-adsorptionl. 
Average size Fraction of spc DNA Total number 
Cell source* OLm) of more than 1 pm (%) per cell 
Primary lymphoid 19-54 80-90 100-200 
tissue cell 
tissue cell 
Secondary lymphoid 1.0-1.8 4&50 50-130 
Primary cell line 1 +2.0 30-60 20-50 
Immortal cell line 0.3-1.0 - 25 400-1200 
Embryonic cell -0.3 3-1 0 100-600 
* Primary lymphoid tissue cell (mouse thymus, bone marrow; chick thymus, bursa): Secondary 
lymphoid tissue cell (mouse spleen, spleen T-cell, lymph node): Primary cell line (human lung; mouse 
liver; chick retina): Immortal cell line (human HeLa; mouse 3T6, L; rat L6): Embryonic cell (mouse 
F9, 3 1 1 ,  early embryo before compaction). 
